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Abstract. The American Society for Tropical Medicine andHygiene recently inaugurated an award for the best clinical
research article published in the society’s journal in the previous year. This article summarizes both the process of
selecting the winner and several themes that stood out in those articles which rose to the top for consideration. Themes
of note included the importance of doing clinical research outside of referral centers, the complexity that must be
considered when implementing interventions, incorporation of both ends of the age spectrum into studies, and con-
sidering cost-effectiveness and opportunity cost of interventions.
INTRODUCTION
Historically, most clinical research projects have been fo-
cused on single disease–oriented topics and conducted in
urban tertiary care centers. Clinical tropical medicine research
efforts have largely followed suit. A developing trend in clinical
research is to look beyond the traditional referral centers and
their patient populations, out into the communities and to in-
tegrate the “horizontal” influences of comorbidities, culture,
health delivery systems, social determinants of health, and
other contexts, rather than maintain an artificially narrow
“vertical” focus on single pathophysiological entities. This
new approach, using community involvement and practice-
based research networks, has the potential to challenge as-
sumptions and uncover new strategies for improving the
health of the individual and the community.1 In our review of
clinical research articles in the journal over the past year, we
found signs of a similar trend brewing in clinical tropical
medicine research.
BEST ARTICLE AWARD
In 2018, the American Committee on Clinical Tropical
Medicine and Travelers’ Health (ACCTMTH), the American
Society for Tropical Medicine and Hygiene’s clinical group,
introduced an award to be given in recognition of the best
clinical research article published in The American Journal of
Tropical Medicine and Hygiene within the previous year. For
the purposes of this award, clinical research was defined as
the branch of health-care science that determines the safety
and effectiveness of medications, devices, diagnostic prod-
ucts, and treatment regimens intended for human use.2 These
may be used for prevention, diagnosis, treatment, or relieving
symptoms of a disease. The scope also included studies
of disease manifestation and progression, clinical epidemio-
logical studies, and case reports of novel presentations or
approaches to diagnosis or treatment. Review articles, meta-
analyses, editorials, and treatment guidelines were excluded
from consideration.
A selection committee of seven members was formed,
composed of volunteers responding to the call for reviewers
from members of ACCTMTH. All members of the committee
were physicians, who have experience in both clinical care
and research, as well as experiences working in global and/or
low-resource settings. Eachmember reviewed, at minimum, a
3-month series of the journal to identify clinical research arti-
cles for consideration. A year’s worth of the journal, published
between July 2017 and June 2018, was culled to 15 candidate
articles in this first step (Table 1).
At least twomembers of the selection committee reviewed
each article identified, writing a summary and providing a
score on a scale of 30. There were no a priori guidelines on
how to score. Reviewers sought to identify those reports that
demonstrated readability for a broad audience, and were
both innovative and relevant with the potential to make a
significant impact on health. The process resulted in three
articles rising above the rest. These “finalists” were then
ranked in order by each committee member, the synthesis of
which resulted in selection of the article which would receive
the honors,3 which were presented at the 2018 Annual
Meeting.4
NATURAL SELECTIONS
In addition to reports of clinical trials involving novel treat-
ments or diagnostic technologies, the breadth of clinical
studies now being published in the journal is impressive. This
is reflected in articles that covered malaria treatment, its
complications, and animal (now human) Plasmodium knowl-
esi; advances in the treatment of leishmaniasis; migration
medicine; water, sanitation, and hygiene; disease elimination
using mass drug treatment; One Health5 themes such as
brucellosis; advances in xenodiagnoses; nosocomial spread
of viral infections such as alpha virus in Asia causing severe
fever and thrombocytopenia; and falsified medications. This
represents a substantial increase in clinically applicable arti-
cles compared with a predominance of preclinical and basic
science reports in the past.
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Some interesting trends were noted in the articles that
emerged through this process. One of the themes was the
importanceofdoing clinical researchoutsideof referral centers.
A prime example of this was the finding that clinical charac-
teristics of severe malaria presenting to rural, peripheral health
centersweredifferent fromthosepreviouslyobserved in referral
centers, and that there may be different methods that are op-
timal for the identification andmanagement of severemalaria in
these settings.3 This result—especially if replicated in similar
settings—emphasizes the importance of conducting clinical
and epidemiological research in the context of the primary care
health system rather than only in larger centers, especially
within narrow silos which can emerge from the way global
health activities are funded by Western interests.
A related theme is the complexitywhichmust beconsidered
when implementing interventions. For example, one in-
vestigative team had a broad enough perspective to look
beyond the narrow focus of the investigation protocol itself
and identified unintended consequences of a well-conceived
public health intervention.6 The reality of applicationmaydiffer
TABLE1
Articles remaining following initial screening step, in alphabetical order by first author
Article Topic Summary
Boyce et al.3*† Sign-disease association About 1/5 of patients with fever in highland Uganda had parasitemia. Severe
malaria manifested as shock and lactic acidosis much more commonly than
severe anemia. Severe malaria had age peaks at 2–3 years and in those
older than 50 years.
Bruxvoort et al.6 Effect of diagnostics on
management
Rapid tests improved appropriate treatment with artemisinin combination
therapy for test-positive and negative cases, but many cases were not treated
according to test results.
Cash-Goldwater et al.11 Infection risk factors Brucellosis confirmed by blood culture, or 4-fold rise in microagglutination was
confirmed or probable in 9% of febrile patients, mostly who attend animals but
were not suspected by medical providers.
Kakio et al.12 Medication quality Studies of dissolution and use of handheld Raman spectrophotometer
device were useful in detecting substandard or falsified medications using
the antihypertensive candesartan as a test product.
Fauver et al.13 Xenosurveillance PCR detected Trypanosoma brucei gambiense, Bacillus anthracis, Middle
East respiratory syndrome–related Coronavirus, and Zika virus in the
blood of Anopheles gambiaemosquitoes fed on blood containing
these pathogens.
Huang et al.14 Outbreak Relatives and a physician who cared for two index cases with this
phlebovirus showed a spectrum of infection from asymptomatic
to severe disease.
Hussain et al.15 Sanitation Use of size-appropriate potties to catch and dispose of fecal material in
children aged 6–36 months rather than open defecation
resulted in improved sanitation. Acceptance varied with shape and
color of the potties.
Lago et al.8† Geriatric treatment Individuals aged 60–85 years responded equally compared with
persons aged 18–40 years but had increased cardiac arrhythmias and
cardiac overload.
Lai et al.16 Diagnostics Plasmodium knowlesi was detected within 20 minutes
with high sensitivity and specificity.
Mitchell et al.17 Refugee health Refugees in three Thailand–Burma border camps were screened and
treated for intestinal parasites, evaluated for chronic hepatitis B, and
screened and treated for anemia in addition to receiving appropriate
vaccines. Results were forwarded to receiving health-care officials in
the United States.
Morris et al.7 Water purification Water quality was improved with the use of ceramic filters
(< 1 Escherichia coli/100 mL). Visits for diarrhea were fewer
in households using filters, but the incidence of diarrhea was
not decreased. Cryptosporidia were not detected in large volumes
of filtered water, and only 2% with ceramic filters.
Oldenburg et al.9† Mass treatment Treatment with azithromycin in 90% of persons in communities
compared with 80% decreased infection (detected by PCR) more rapidly,
but at 36 months, results were similar.
Pandey et al.10 Pediatric treatment Administration of a single dose of liposomal amphotericin in 100 children
with visceral leishmaniasis in India resulted in a cure rate of 100% at
1 month and 98% at 6 months. Fever and chills were side effects, but no
nephrotoxicity was noted.
Poespoprodjo et al.19 Antimalarials Once-daily treatment for 3 days resulted in clearance of 97.7% of
P. falciparum and 98.2% of P. vivax cases by day 2.
Day 42 efficacy was 97.7% and 98.2%, respectively.
No genes associated with resistance were detected.
Refai et al.18 Non-pharmacologic treatment Single 30-second heat treatment to 50C was compared with treatment
with intralesional stibogluconate in solitary lesions. Clinical response
was faster in heat-treated lesions at 8 and 10 weeks, but similar thereafter.
Heat treatment was well tolerated, less expensive, and painful than repeated
intralesional injections.
* Ultimate selection.
† Three finalists.
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from the ideals of implementation because of complex inter-
actions of many factors in the patient, the health system, and
the community. As part of their discussion, they observed, “A
more comprehensive approach to case management is
needed, rather than focusing on only a single diagnosis and
treatment.”6 This points to patient-oriented outcomes, rather
than mere surrogate markers, as the true indicators of suc-
cess. Patient-oriented outcomes are difficult to affect and
measure because of the many factors in play. Another group
included patient-oriented outcomes in the study design but
ultimately emphasized a surrogate outcome when no signifi-
cant effect was seen in the former.7
Another theme was the importance of incorporation of
both ends of the age spectrum. The inclusion of geriatric
populations—a group that is often neglected but is in-
creasing in size in tropical clinical research—was refresh-
ing.8 So, too, was the inclusion of the young.9,10Whereas the
findings may not have been surprising in terms of both effi-
cacy and tolerability in children comparedwith young adults,
toxicity in older patients with cutaneous leishmaniasis
treated with systemic antimony drugs was increased to the
point that it is not recommended.8 It was good to see actual
data rather than leaving clinicians to extrapolate based
on nonsimilar patient populations when making treatment
decisions.
Finally, the importance of assessing cost-effectiveness and
opportunity cost was apparent from the selected literature. Just
because we can do something does not mean that we
should—perhaps greater impact may be found elsewhere. One
of the articles nicely describedwhydiverting resources to extend
the current 80% coverage of the intervention to 90% would
not meaningfully decrease overall prevalence of the targeted
disease. Instead, the resources could potentially make more
significant health improvements if allocated to other areas.9
SPONTANEOUS GENERATION
In selecting the “best clinical research article,” the com-
mittee was attempting to predict the future by identifying the
work that will have the greatest effect on health in the tropics.
The perspective reported here does not reflect a systematic
review of the literature. It is the observation that those articles
which most impressed the committee seemed to share these
themes in common. The themes were not a priori selection
criteria; they emerged from an ad hoc process affected by the
shared biases of the selection committee. Ideally, these are
biases which value recognition of a changing culture within
clinical research, one that favors a more integrated and
comprehensive approach to clinical tropicalmedicine research.
We believe that the future will be shaped by well-designed
studies that consider the entire community, including the
complexity of interactions, the full span of its ages, and its
priorities for health.
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